Beginner's Mind

Welcome to the year-in-review podcast for 2022! As the year comes to a close, I am excited to reflect on the successes and learnings from the past 12 months and look ahead to what 2023 has in store. I have an incredible lineup of speakers from 90 previous podcast episodes; the event was live-streamed before Christmas on LinkedIn, YouTube, Twitter, and Facebook, so listeners could tune in from anyw...

In this episode, I unlock the untold stories behind PayPal's meteoric rise and the entrepreneurs who made it possible. The author Jimmy Soni explores the captivating story of PayPal and the entrepreneurs who helped shape Silicon Valley. From Elon Musk to Peter Thiel and many others whose stories have never been told, hear about the scrappy online payments start-up that faced fierce competitio...

As the holiday season has started, I wanted to take a moment to wish you all a very Merry Christmas. I hope this time of year brings you joy, peace, and happiness. Remember to stay positive and hopeful as we look ahead to the new year.  2023 is a new opportunity to set goals, make positive changes, and achieve our dreams. I hope you can spend this holiday season with loved ones, surrounded by warm...

Which Role do Wearables like Virtual Reality Devices play in the Future of Diagnostics? In this episode, I am excited to talk with Adrian Brodesser, CEO of Somareality, to explore the latest technological developments and their impact on society. Adrian will be joining us to discuss the use of VR in diagnosing neurological diseases and how these devices are revolutionizing the way we approach heal...

What is the Role of Biophysics in Drug Development and Drug Discovery? In this episode, I speak with Dr. Thomas Schubert, CEO of 2bind, a provider of biophysical outsourcing solutions for the pharmaceutical. Dr. Schubert discusses the role of biophysics in drug development and the importance of outsourcing in the pharmaceutical industry. ⭐ In this episode, we talk about: The Role of Biophysics in...

How did Venture Capital evolve? When did it start? Get the answers right here in the book The Power Law by Sebastian Mallaby. ⭐ In this episode, we talk about: • Storytelling Methods and a Writers Work Process • What is Venture Capital – From the Writers Perspective • How Did Silicon Valley Evolve into the Center of the Innovation World? • The 3 Most Crucial Moments in the Development of Venture...

What is the Role of Artificial Intelligence in Drug Development and Drug Discovery? ⭐ In this episode, we talk about: Deep Mind’s Alphafold Investing in Life Science companies The State of AI in Drug Development and Drug Discovery How does GDPR limit the development of AI in Drug Discovery The Human Genome and AI Today’s speaker is Marco Schmidt, CSO of Biotx.ai Marco had an exceptional academic...

Do you understand the dynamics of the stock market? Here is an episode with Brian Feroldi, Writer at the Motley Fool, on his new book “Why the stock market goes up?” We are talking about ⭐ The Global Problem With Financial Literacy ⭐ Why Did Brian Feroldi Write a Book About Investing for Beginners? ⭐ Why Does the Market Crash from Time to Time? ⭐ Cost Averaging and Index Investing – A Powerful...

Where are the Big Life Science Hubs in the United States?  Here is an in-depth overview of  Life Science In Georgia with many essential Key Facts and exciting stories from the beautiful state. My guest in this episode is E Jane Caraway, Director of Life Science at the Georgia Department of Economic Development. ⭐We are talking about Life Science, Vineyards, Vampires and Zombies Boehringer Ingelhe...

What are the opportunities for Biotechs in the Chinese Market? Get answers to this question in this podcast with the BFC Group. ⭐We are talking about The BFC Group The Capital Market Landscape in China Deal Structuring in China Clinical Strategies for China Why Affordability and Accessibility of new drugs matter in China ⭐About BFC Group: BFC Group is a China-based investment banking firm with a...

Fundraising in Israel and the United States – In this episode, I have a conversation with Tuvik Beker, CEO of Pangea Biomed, who has started, developed, and exited companies in the United States and Israel. Now he is developing Pangea Biomed to start the next revolution in precision oncology. Tuvik Beker is a seasoned entrepreneur, an experienced executive, and a strong technical leader who spent...

In this episode, Tobias Silberzahn, McKinsey talks about biohacking 101 – habits that make a difference, digital health eco-system, and much more… Tobias Silberzahn is a trained biochemist and immunologist and works as a Partner in McKinsey's Berlin office, where he is a member of the Healthcare and Innovation Practice. His work focuses on healthcare innovation, health tech business-building,...

What are decentralized clinical trials?  What are the benefits of decentralized clinical trials? Why are decentralized clinical trials the way of the future? Emily Mitchell,   Executive Director of ICON’s DCT team, discusses the benefits of these trials and what needs to be considered to ensure these benefits are realized.  Emily Mitchell has over 15 years of experience working in the CRO industry...

What is the best approach to starting a novel deep tech life science company? In this episode, I am talking with Samatha Dale Strasser, CSO , and co-founder of Pepper Bio , about her academic career at the University of Cambridge and MIT and the process of starting Pepper Bio. Backed by VC firm NFX, Pepper Bio uses proprietary lab methods and computational abilities to unlock a new level of sophis...

What is the best methodology for presenting your Company to investors, industry partners, and public funding organizations? Here is the answer: In this episode, Donna LaVoie presents her famous “15-slides-methodology” in great detail. Donna is a proven strategic communications leader in health and science innovation. She is a trusted advisor on strategic communications issues, especially around co...

Happy Birthday, Inits. Today 20 years ago – July 27, 2002 – Inits – Vienna’s most important high Tech Incubation Program was created. In this episode, I am talking with Irene Fialka , CEO of Inits. In 20 years, Inits has supported over 300 high-tech #startups with the necessary tools for a successful and sustainable market entry. Dr. Irene Fialka is CEO of INiTS, Vienna’s University Business Incub...

What is happening in all things digital assets, cryptocurrencies, NFTs, and alike? The market crashed. Is it all over now?  Investing with experts is always the best idea when investing in new areas. This episode was recorded in February 2022, and I am happy that I had the chance to speak with two experts in digital assets from Austria: Astrid Woollard and Christian Niedermüller , SMAPE Capital As...

It is the 80th episode on my podcast channel. In 2020 I wanted to try how podcasts can bring value to my life science business community. One of the first speakers on the podcast was Alexander Belcredi, Phagomed. He and Co-CEO Lorenzo Corsini started their Company in 2015 and developed Alternatives to Antibiotics.; which was also the title of Episode #9 - Alternatives to Antibiotics. In April 2020...

These days many sources are highlighting the shocking scale of the global mental health crisis and how this affects approx—a staggering one billion people worldwide - over one-seventh of the global population. “Unfortunately, as harrowing and monstrous this number is”, the investor Christian Angermayer wrote in a blog post, “it is my belief this is a gross UNDER-estimate.” Ultimately, the number o...

Warren Buffett recommends buying companies with a great moat. Something that makes the company unique and protects the business from the competition. Patents are the best moats. Do you want to know why? Then listen to Gerda Redl. Who is the speaker? Dr. Gerda Redl is a patent attorney with more than 20 years of experience in the life sciences industry. Her technical expertise is in biotechnology,...

What is going on in the world of digital assets in 2022? In May 2010, 10,000 BTC bought 2 Pizza. Last year in November, the same amount had a value of 600 Million dollars. A lot has evolved since 2010 in the digital asset ecosystem. That's why I asked Alexander Valtingojer , CEO of Coinpanion , to discuss the latest development in the crypto market. This episode was recorded in January 2022....

How Did the Conference Industry Change in the last two years?  Philadelphia in 2019 was the last Bio I attended in person. In March 2020, the world shut down to respond to the novel viral threat. Since then, all conferences have been digital.   What effect did this have on the conference Industry – especially the Bio US ? Listen to Rich Masters , Chief Public Affairs and Marketing Officer of Bio....

Are you interested to expand your business into Asian Markets? Then this episode might be for you.  As Program Manager of the Global Incubator Network Austria (GIN) , Lisa Stöger has successfully connected the Austrian startup ecosystem with the world's most innovative startup hubs for the last 4 years. With a focus on Asian markets, she supports Austrian startups in their internationalizatio...

Do you want to know why networking and leadership are so important to be successful in business? And why everybody, including employees, needs to learn those skills?  Then this episode is for you.  Mark is the author of The Career Toolkit, Essential Skills for Success That No One Taught You. Educated at MIT, Mark has spent his career launching and fixing new ventures at startups, Fortune 500s, and...

Do you want to know how to value a company and what Julia Roberts has to do with it? Then listen to Bharat Kanodia in this episode number 73. Valuation is one of the most difficult exercises in the startup world. How can you put a price tag on a company that doesn’t exist yet? Get help from an expert:  Bharat Kanodia has valued over 2000 businesses and signed off on assets worth $2.6 trillion in v...